Top Sell
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Evoke Pharma Inc. | 0 | 25 | 0 | 2 | €0.37 | - | - |
Moleculin Biotech Inc | 3 | 25 | 0 | 3 | €0.41 | €18.42 | 4393.659% |
Trevena Inc. | 2 | 23 | 0 | 2 | €0.15 | €6.48 | 4136.601% |
InVivo Therapeutics Holdings | 0 | 13 | 0 | 0 | €0.31 | - | - |
Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
Minerva Neurosciences Inc. | 0 | 10 | 0 | 1 | €2.34 | - | - |
Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
Organovo Holdings Inc. | 0 | 9 | 0 | 1 | €0.50 | - | - |
Waters Corp. | 0 | 6 | 0 | 0 | €307.80 | €265.52 | -13.735% |
Glycomimetics Inc. | 3 | 7 | 0 | 4 | €0.15 | €9.13 | 6199.724% |
T2 Biosystems Inc. | 0 | 3 | 0 | 0 | €0.16 | - | - |
Integra LifeSciences Holdings Corp | 3 | 6 | 0 | 2 | €17.30 | €31.62 | 82.748% |
Coherus Bioscien. | 0 | 2 | 0 | 0 | €1.18 | - | - |
Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.01 | €5.00 | 149.377% |
NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.48 | - | - |
Vaxart Inc. | 0 | 1 | 0 | 0 | €0.78 | - | - |
Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €6.90 | €58.50 | 747.826% |
Fibrogen Inc. | 0 | 1 | 0 | 0 | €0.37 | - | - |
Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
Atara Biotherapeutics Inc. | 2 | 2 | 0 | 0 | €0.37 | €3.00 | 716.549% |
Aspira Womens Health Inc. | 1 | 1 | 1 | 0 | €0.82 | €4.99 | 512.564% |
Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.20 | €7.31 | 128.307% |
Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 97.287% |
Bluebird Bio Inc. | 7 | 6 | 3 | 0 | €0.51 | €5.47 | 973.412% |
Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.08 | €50.00 | 4538.219% |